Abstract: A method, apparatus, and program product are provided for integrating a calendar todo list with information from other applications. The method comprises the steps of: dynamically extracting data for open application processes, and creating task listings using the data for the open application processes. The apparatus comprises a processor adapted to dynamically extract data for open processes and create task listings using the data for the open application processes, and a memory having stored thereon a calendar application with a list of tasks. The program product comprises a machine readable media having encoded thereon, machine executable instructions for dynamically extracting data for open application processes, and creating task listings using the data for the open application processes.

Abstract: The present invention relates to fusion proteins containing at least two Mycobacterium tuberculosis antigens. In particular, it relates to bi-fusion proteins which contain two individual M. tuberculosis antigens, tri-fusion proteins which contain three M. tuberculosis antigens, tetra-fusion proteins which contain four M. tuberculosis antigens, and penta-fusion proteins which contain five M. tuberculosis antigens, and methods for their use in the diagnosis, treatment and prevention of tuberculosis infection.

Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: A method and system are described for protecting a manufactured item from counterfeiting. The manufactured item, which is marked with an identifier, such as a serial number, is associated with a code generator that has secret functions and data for generating verification codes. The manufactured item is then supplied along with the corresponding code generator. Thereafter, the identifier from the manufactured item and the verification code generated by the code generator are used to verify authenticity of the manufactured item.

Abstract: A method and a system for power saving and state retention in an electronic device are provided. The method for power saving and state retention in an electronic device includes recording a state variation of electronic components of a plurality of groups in a second circuit of the electronic device in a variation table stored in memory of a first circuit or the second circuit of the electronic device; before stopping providing power to the second circuit, selecting some groups from the plurality of groups according to the variation table and making a backup of states of electronic components of the selected groups; and after restoring power to the second circuit, restoring the states of electronic components of the selected groups according to states in the backup.

Abstract: Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more M. tuberculosis proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against M. tuberculosis infection, or may be used for the diagnosis of tuberculosis.

Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: The present invention relates to fusion proteins containing at least two Mycobacterium species antigens. In particular, it relates to nucleic acids encoding fusion proteins that include two or more individual M. tuberculosis antigens, which increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: A cage for use in a roller bearing, said cage comprising a pair of generally semicircular molded plastic parts joined together, the molded plastic parts each comprising a set of pockets for receiving and locating rollers, and releasable fixings at their ends, wherein two generally semicircular molded plastic parts are detachably interconnected to each other by inter-engagement of their respective releasable fixings to form a complete generally circular cage.

Abstract: A method, apparatus and program product are provided for moving data from a source memory zone to a target memory zone of a computer. A source host operating system invokes a synchronous multiple move command for SBAL output buffers with a common target zone. The machine firmware identifies and validates the target argument of the first SBAL, validates the target zone state, moves the data associated with the first SBAL to the target zone; and then iteratively moves the data associated with the remaining SBALs to the target zone.

Abstract: The present invention relates to a process for animal, preferably human, diploid anchorage-dependent cell culture, in the absence of exogenous components of primary animal origin, and to a cell culture medium substantially free of exogenous components of primary animal origin suitable for carrying out said process. In particular the invention concerns a cell culture medium which comprises at least one, more preferably several, exogenous animal-free growth factors. The present invention also relates to a process for cultivating animal, preferably human diploid anchorage-dependent cells in a medium according to the invention, involving the use of a trypsin substitute of non-animal origin for passaging cells. The invention further relates to a process for producing viruses, viral vaccines and the like.

Abstract: Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more M. tuberculosis proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against M. tuberculosis infection, or may be used for the diagnosis of tuberculosis.

Abstract: The present invention relates to fusion proteins containing at least two Mycobacterium species antigens. In particular, it relates to nucleic acids encoding fusion proteins that include two or more individual M. tuberculosis antigens, which increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.

Abstract: A portable device comprising a modular movement is disclosed. The modular movement has a body housing a plurality of layers that include a top layer of glass, and a movement subassembly for displaying information, including time, wherein the modular movement includes all parts necessary for power and operation, including the displaying of the information, such that the modular movement is fully functional standalone. The portable device further includes a case, which includes a receptacle for removably receiving the modular movement without need for a tool, such that the modular movement is user-interchangeable with another case of another portable device.

Abstract: Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed.

Abstract: Compounds and methods for diagnosing tuberculosis or for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA molecules encoding such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Mycobacterium infection in patients and biological samples. Antibodies directed against such polypeptides are also provided. In addition, such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against Mycobacterium infection.

Abstract: Compounds and methods for diagnosing tuberculosis or for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA molecules encoding such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Mycobacterium infection in patients and biological samples. Antibodies directed against such polypeptides are also provided. In addition, such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against Mycobacterium infection.